Papers - YONEYAMA Tohru
-
Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.
Takuya Koie, Yasuhiro Hashimoto, Atsushi Imai, Tohru Yoneyama, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Tadashi Suzuki
International urology and nephrology 2020.9
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).
Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 2020.8
-
Geriatric 8 screening of frailty in patients with prostate cancer.
Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 642 - 648 2020.8
-
Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function.
Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Transplantation proceedings 52 ( 6 ) 1723 - 1728 2020.8
-
The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
International urology and nephrology 52 ( 8 ) 1421 - 1428 2020.8
-
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Koichi Kido, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Urologic oncology 38 ( 8 ) 684.e17-684.e24 - 684.e24 2020.8
-
Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 649 - 654 2020.8
-
Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.
Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Urologic oncology 2020.7
-
Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).
Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 2020.7
-
Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.
Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Urologic oncology 2020.7
-
The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.
Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Neurourology and urodynamics 39 ( 5 ) 1567 - 1575 2020.7
-
Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.
Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama
Clinical and experimental nephrology 24 ( 7 ) 638 - 645 2020.7
-
Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.
Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
IJU case reports 3 ( 4 ) 141 - 144 2020.7
-
Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function
Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Transplantation Proceedings 52 ( 6 ) 1723 - 1728 2020.7
-
Outcome of ABO Blood Type–Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan
Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Transplantation Proceedings 52 ( 6 ) 1700 - 1704 2020.7
-
Frailty is a predictor of moderate to severe pain after robot-assisted laparoscopic prostatectomy: A case-control study (FRAP study).
Masaki Momota, Shingo Hatakeyama, Osamu Soma, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BJUI compass 1 ( 3 ) 100 - 107 2020.7
-
Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.
Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
IJU case reports 3 ( 4 ) 141 - 144 2020.6
-
Geriatric 8 screening of frailty in patients with prostate cancer.
Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 642 - 648 2020.6
-
尿路結石バイオマーカーとして尿中糖鎖変異オステオポンチン(PolyLacNAc-OPN)の同定
阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 伊藤 淳, 海法 康裕, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力
泌尿器科紀要 66 ( 6 ) 180 - 180 2020.6
-
The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.
Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Neurourology and urodynamics 39 ( 5 ) 1567 - 1575 2020.5